Each pharmaceutical company should visually identify materials of promotional or non-promotional nature that may be provided to healthcare professionals as those which belong to non-prescription medicines. Here always chepest way to buy medicines in online pharmacy in australia by visitng this website. Simply when you need to order levaquin tablets. It may be ideal choice to go on the market. The ethical promotion of prescription medicines is vital to the pharmaceutical industry’s mission of helping patients by discovering, developing and marketing new medicines. Generic alternative of levaquin price is always reduced when ordered in online pharmacy. Especially in australia. The pharmaceutical industry has an obligation and responsibility to provide accurate information and education about its products to healthcare professionals in order to establish a clear understanding of the appropriate use of prescription medicines. Details about kamagra product line by Adjanta can be obtained on blog, you have chance to get kamagra online in uk. kamagra is one of the bestselling medicines online in uk. If you are looking info about naltrexone ldn just navigate this.

New Clinical Trial for Non-squamous Non-small Cell Lung Cancer

Posted by ALCF Staff on March 28th, 2017
No Comments

A new study led by researchers at the Indiana University Melvin and Bren Simon Cancer Center may help answer questions about the role of immunotherapy in combination with chemotherapy in treating lung cancer patients whose disease worsened after initial response to immunotherapy. The randomized phase II study, known as HCRN LUN15-233, involves Taxotere® with or without Opdivo®. About 58 subjects will participate in the study, and will be randomized to one of two treatment arms. Arm A will receive Taxotere plus Opdivo, while Arm B will receive Opdivo alone. Eligible subjects must have advanced non-squamous non-small cell lung cancer with previous clinical benefit on treatment with single agent Opdivo. Additional criteria must be met to enroll. Learn more at http://hoosiercancer.org/clinical-trials/trial/lun15-233/.

About Guneet Walia, PhD

Dr. Guneet Walia is here to serve as your guide through what can feel like an overwhelming amount of information and jargon in lung cancer research. With her extensive background in oncology & drug development in the lab and experience working with cancer patients, she culls through the latest news to bring you the most important developments that can impact you and your disease today. If you have any questions, please don't hesitate to get in touch with Dr. Walia.
Leave a Reply: